ganoderic acid C2
Identification
| Name | ganoderic acid C2 |
| CAS Number | 98296-48-1 |
| FDA UNII | Search |
| Molecular Formula | C30 H46 O7 |
| Molecular Weight | 518.69102000 |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Soluble in | water, 0.6764 mg/L @ 25 °C (est) |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for ganoderic acid C2 usage levels up to | not for fragrance use. |
| Recommendation for ganoderic acid C2 flavor usage levels up to | not for flavor use. |
BOC Sciences
Best of Chemicals Supplier
Quality supplier of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecul...
Potential Uses
Natural Occurrence
Synonyms
2-
methyl-4-oxo-6-(3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl)heptanoic acid
PubMed:
Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
PubMed:
Ganoderic Acid A Metabolites and Their Metabolic Kinetics.
PubMed:
Hepatoprotective Effects and Mechanisms of Action of Triterpenoids from Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) on α-Amanitin-Induced Liver Injury in Mice.
PubMed:
[Determination of nine triterpenoid acids from Ganoderma lucidum of different producting areas by HPLC].
PubMed:
Structural characterization of minor metabolites and pharmacokinetics of ganoderic acid C2 in rat plasma by HPLC coupled with electrospray ionization tandem mass spectrometry.
PubMed:
Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease.
PubMed:
Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.
PubMed:
Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum.
PubMed:
[Simultaneous HPLC determination of four triterpenoid acids in Ganoderma lucidum].
PubMed:
[Chemical constituents of the spores of Ganoderma lucidum].
PubMed:
Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.